Levonorgestrel News and Research

RSS
Bayer announces updated labels for drospirenone-containing COCs in the U.S.

Bayer announces updated labels for drospirenone-containing COCs in the U.S.

Morning after pills difficult for teenagers to procure

Morning after pills difficult for teenagers to procure

HHS: Plan B access will stay limited

HHS: Plan B access will stay limited

Watson introduces Amethia Lo and ethinyl estradiol tablets

Watson introduces Amethia Lo and ethinyl estradiol tablets

Oral hormonal contraceptives linked to blood clots: Study

Oral hormonal contraceptives linked to blood clots: Study

FDA: Study suggests increased risk of blood clots from drospirenone-containing contraceptives

FDA: Study suggests increased risk of blood clots from drospirenone-containing contraceptives

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Safety of birth control pills under scrutiny

Safety of birth control pills under scrutiny

Birth control pill safety issues raised

Birth control pill safety issues raised

Sosei to introduce NorLevo oral emergency contraceptive in Japan

Sosei to introduce NorLevo oral emergency contraceptive in Japan

Newer birth control pill raises risk of blood clots

Newer birth control pill raises risk of blood clots

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack

Bayer's birth control pills may increase risk of venous thromboembolism

Bayer's birth control pills may increase risk of venous thromboembolism

Contraception drospirenone raises risk for blood clots

Contraception drospirenone raises risk for blood clots

Drospirenone doesn't carry any risk of gall bladder disease

Drospirenone doesn't carry any risk of gall bladder disease

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit

Study finds increased risk of VTE during first year of combination oral contraceptive usage

Study finds increased risk of VTE during first year of combination oral contraceptive usage

Japan MHLW approves Sosei's NorLevo emergency contraceptive pill

Japan MHLW approves Sosei's NorLevo emergency contraceptive pill

WomanCare Global expands product portfolio to include Roselle, Optinor

WomanCare Global expands product portfolio to include Roselle, Optinor

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

Agile presents AG200-15 contraceptive patch Phase 2 clinical study results at 66th ASRM

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.